Find comprehensive information on Narcotic Dependence, including clinical documentation, medical coding (ICD-10 F11.20, DSM-5 Opioid Use Disorder), signs and symptoms, withdrawal management, and treatment options. This resource supports healthcare professionals in accurate diagnosis, coding compliance, and effective patient care related to opioid addiction and substance use disorders. Learn about opioid dependence criteria, screening tools, and best practices for documenting narcotic dependence in medical records.
Also known as
Opioid Dependence
Dependence on heroin, opium, or other opioids.
Other Opioid Dependence
Dependence on synthetic opioids like methadone.
Unspecified Opioid Dependence
Dependence on opioids when the specific type is unknown.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the narcotic dependence confirmed?
When to use each related code
| Description |
|---|
| Opioid dependence, physiological & behavioral |
| Opioid withdrawal |
| Opioid abuse |
Coding narcotic dependence without specifying opioid, synthetic, or other type leads to inaccurate severity and reimbursement.
Failing to capture co-existing mental health conditions like anxiety or depression with narcotic dependence impacts treatment and payment.
Lack of documentation clarifying early, sustained, or in remission status for narcotic dependence affects quality reporting and care plans.
Patient presents with opioid dependence, fulfilling DSM-5 criteria for opioid use disorder, characterized by a problematic pattern of opioid use leading to clinically significant impairment or distress. Symptoms include craving for opioids, tolerance requiring increased doses for desired effect, withdrawal symptoms upon cessation or dose reduction, and unsuccessful efforts to cut down or control use. The patient reports spending a significant amount of time obtaining, using, or recovering from opioid use, neglecting social, occupational, or recreational activities. Continued use despite negative consequences related to physical health, interpersonal relationships, and employment is evident. Physical examination reveals mild pupil constriction and evidence of prior intravenous drug use. Assessment indicates moderate opioid dependence severity. Differential diagnosis includes chronic pain syndrome, anxiety disorders, and depression. Treatment plan includes referral to addiction medicine specialist for medication-assisted treatment with buprenorphine-naloxone, individual therapy focusing on relapse prevention and coping skills development, and support group participation. Patient education provided on opioid overdose risks, naloxone administration, and harm reduction strategies. Prognosis guarded but improved with adherence to treatment recommendations. Follow-up scheduled in one week to monitor treatment response and address any withdrawal symptoms. ICD-10 code F11.20 Opioid dependence, unspecified is assigned.